Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Heaven-Sent Gold / Equity Capital Markets

<p>Heaven-Sent Gold started book building today to raise up to USD 180 million to listing in Hong Kong. The company acquired the gold mine in South African in 2015 and in just four years time it is trying to list the gold mining assets.</p>
<p>In this insight, we will briefly discuss the company's background and financials. Given its loss-making status, we are not keen to participate in the deal, though the deal is heavily anchored by listed mining companies. </p>

Heaven-Sent Gold started book building today to raise up to USD 180 million to listing in Hong Kong. The company acquired the gold mine in South African in 2015 and in just four years time it is trying to list the gold mining assets.
In this insight, we will briefly discuss the company's background and financials. Given its loss-making status, we are not keen to participate in the deal, though the deal is heavily anchored by listed mining companies. 

Heaven-Sent Gold (硅谷天堂黄金) IPO: An OTM Option